Tagra Biotechnologies recently released CelluCapTM for long-lasting retional and vitamin A ingredients. The leading microencapsulation allows ingredients to remain fresh and only be released when the user applies them to their skin.
The CelluCapTM R and CelluCapTM A ensure these active ingredients remain fully potent and effective longer. This is because these ingredients beloved for their anti-aging properties are sensitive to oxidation and degrade " in the presence of air, sunlight, acidic conditions, and heavy metals, making them less stable and potent (and therefore, less effective)."
To keep these ingredients potent, Tagra Biotechnologies created a single layer of polymeric shell that collapses and breaks down into invisible particles when applied, "yet still retains its stability to continue delivery over time."
Long-Lasting Skincare Ingredient Packaging
Tagra Debuts CelluCap for Retinol and Vitamin A
Trend Themes
1. Long-lasting Skincare Ingredient Packaging - Tagra's CelluCapTM packaging provides a disruptive innovation opportunity for companies in the skincare industry to extend the shelf-life of sensitive ingredients and improve product effectiveness.
2. Microencapsulation Technology - Tagra's innovative use of microencapsulation technology provides a disruptive innovation opportunity for companies in various industries, such as pharmaceuticals and food, to enhance the stability and shelf-life of reactive ingredients.
3. Targeted Ingredient Delivery - Tagra's CelluCapTM technology that allows for targeted and controlled ingredient release presents a disruptive innovation opportunity for companies in the cosmetics and medicine industries to develop highly precise and effective products.
Industry Implications
1. Skincare - Companies in the skincare industry can benefit from Tagra's invention by extending the life of sensitive ingredients and improving product efficacy, which addresses consumer demand for longer-lasting and highly effective skincare products.
2. Pharmaceutical - Tagra's microencapsulation technology provides pharmaceutical companies with a disruptive innovation opportunity to enhance the stability of reactive drugs, which results in longer shelf-lives, lowered costs, and greater efficacy.
3. Food - Food companies could take advantage of Tagra's microencapsulation technology to enhance the effectiveness, safety, and shelf-life of reactive ingredients such as nutrients, flavors, and preservatives.